Hamilton Thorne Ltd. Shares Soar 5.2% on Monday
May 24, 2023
Trending News ☀️
On Monday, the shares of Hamilton Thorne ($TSXV:HTL) Ltd. surged by 5.2%, continuing the surge in stock prices that the company has seen over the past two months. Hamilton Thorne Ltd. is a Canadian biotechnology company that specializes in providing products, services, and education in the fields of fertility and cell biology. By leveraging its advanced instruments, software, and services, Hamilton Thorne provides solutions to enable research, drug discovery, and in vitro fertilization (IVF) laboratories to revolutionize their processes. With further growth expected in the near future, Hamilton Thorne Ltd.’s shares are likely to continue to rise.
Analysis
At GoodWhale, we have analyzed the fundamentals of HAMILTON THORNE and have identified it to be a high-risk investment from both financial and business perspectives. Our Risk Rating feature has revealed certain red flags that you should consider before investing. From the income sheet, balance sheet and cashflow statement, we have detected three risk warnings. While these warnings don’t necessarily mean that HAMILTON THORNE is a bad investment, they should be considered in order to make the most informed decision. If you would like to learn more about these warnings, please register on our website at goodwhale.com. Our team of experts are available to answer your questions and provide further insights into HAMILTON THORNE’s fundamentals. More…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Hamilton Thorne. More…
| Total Revenues | Net Income | Net Margin |
| 57.37 | 1.77 | 2.9% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Hamilton Thorne. More…
| Operations | Investing | Financing |
| 2.23 | -2.58 | -2.01 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Hamilton Thorne. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 70.27 | 17.5 | 0.37 |
Key Ratios Snapshot
Some of the financial key ratios for Hamilton Thorne are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 20.7% | -3.9% | 4.8% |
| FCF Margin | ROE | ROA |
| -0.6% | 3.2% | 2.5% |
Peers
In the field of medical research equipment, there is intense competition between Hamilton Thorne Ltd and its main competitors, Hangzhou Alltest Biotech Co Ltd, Caina Technology Co Ltd, and Hainan Shuangcheng Pharmaceuticals Co Ltd. All of these companies are striving to develop the most innovative and effective products possible in order to gain market share. This competition is beneficial for consumers as it drives down prices and encourages companies to continuously improve their products.
– Hangzhou Alltest Biotech Co Ltd ($SHSE:688606)
Hangzhou Alltest Biotech Co Ltd is a biotechnology company that focuses on the research and development, production, and sales of in vitro diagnostic reagents and instruments. The company has a market capitalization of 6.37 billion as of 2022 and a return on equity of 27.91%. Alltest Biotech’s products are used in the fields of medical diagnosis, food safety, and environmental testing. The company’s products are sold to customers in China and overseas markets.
– Caina Technology Co Ltd ($SZSE:301122)
Caina Technology Co Ltd is a Chinese company that manufactures integrated circuits and other semiconductor products. It has a market capitalization of 5.22 billion as of 2022 and a return on equity of 7.44%. The company’s products are used in a variety of electronic devices and components, including mobile phones, computers, and automobiles. Caina Technology is headquartered in Shenzhen, Guangdong Province, China.
– Hainan Shuangcheng Pharmaceuticals Co Ltd ($SZSE:002693)
Hainan Shuangcheng Pharmaceuticals Co Ltd is a Chinese pharmaceutical company with a market cap of 4.59B as of 2022. The company’s ROE is -3.09%. The company manufactures and sells pharmaceutical products, medical devices, and health food products.
Summary
Hamilton Thorne Ltd. has had a positive Monday, with shares of the company trading up 5.2%. Investing in Hamilton Thorne can be a smart move for traders, as the company has a strong track record of consistent growth and financial stability. It is well-established in its industry, and its products and services are in high demand. The company also has an extensive research and development pipeline, which helps it stay ahead of the market.
Further, its management team is experienced and committed to creating value for its shareholders. Investors should monitor the company’s financials and news closely to stay informed of any changes in the company and its share price.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
